Julius Clinical’s Post

Today marks the start of the Alzheimer Europe Conference in Geneva. Over the next few days there will be many clinical insights and research highlights discussed. We are ready and set-up at booth number 5. #34AEC #AlzheimersDisease #AlzheimersAwareness

🎧 Thanks to medical advances, we're living longer but with that comes rising rates of Alzheimer's. However, promising new drugs that slow cognitive decline could help. In our latest #UnseenUpside episode, we explore the history of Alzheimer’s, who it affects, its current challenges, and the promising therapies at the forefront of innovation and investment. Check it out: https://ow.ly/yeyZ50QFHlv

🎧 Thanks to medical advances, we're living longer but with that comes rising rates of Alzheimer's. However, promising new drugs that slow cognitive decline could help. In our latest #UnseenUpside episode, we explore the history of Alzheimer’s, who it affects, its current challenges, and the promising therapies at the forefront of innovation and investment. Check it out: https://ow.ly/UVmp50QFBjY

We are in a time of unprecedented promise and progress in Alzheimer's research and treatment. Research shows that there are actionable steps we can take to reduce our risk of developing Alzheimer's in the first place. Join us for Advancing the Science on March 13th, where you will have the opportunity to: 🧠 Learn about the latest advancements in Alzheimer's research and treatment. 💡 Gain insights from experts on how to take preventive measures to reduce the risk of developing Alzheimer's. Register today at tinyurl.com/advscimar13. #ENDALZ

🎧 Thanks to medical advances, we're living longer but with that comes rising rates of Alzheimer's. However, promising new drugs that slow cognitive decline could help. In our latest #UnseenUpside episode, we explore the history of Alzheimer’s, who it affects, its current challenges, and the promising therapies at the forefront of innovation and investment. Check it out: https://ow.ly/UgXh50QIoMT

🎧 Thanks to medical advances, we're living longer but with that comes rising rates of Alzheimer's. However, promising new drugs that slow cognitive decline could help. In our latest #UnseenUpside episode, we explore the history of Alzheimer’s, who it affects, its current challenges, and the promising therapies at the forefront of innovation and investment. Check it out: https://ow.ly/E4FN50QFLRy

🎧 Thanks to medical advances, we're living longer but with that comes rising rates of Alzheimer's. However, promising new drugs that slow cognitive decline could help. In our latest #UnseenUpside episode, we explore the history of Alzheimer’s, who it affects, its current challenges, and the promising therapies at the forefront of innovation and investment. Check it out: https://ow.ly/q58S50QFIny

🎧 Thanks to medical advances, we're living longer but with that comes rising rates of Alzheimer's. However, promising new drugs that slow cognitive decline could help. In our latest #UnseenUpside episode, we explore the history of Alzheimer’s, who it affects, its current challenges, and the promising therapies at the forefront of innovation and investment. Check it out: https://ow.ly/6wxM50QFHE8

Experience the innovative strides of #ImagingTechnology in advancing Alzheimer's research! 🧠 Tune in to our engaging discussion with Prof. Russ Hornbeck as we uncover the insights behind the DIAN study, data harmonization, and #ImagingBiomarkers. Watch now: https://bit.ly/3vFmdMG

🎧 Thanks to medical advances, we're living longer but with that comes rising rates of Alzheimer's. However, promising new drugs that slow cognitive decline could help. In the latest #UnseenUpside episode, we explore the history of Alzheimer’s, who it affects, its current challenges, and the promising therapies at the forefront of innovation and investment. Listen now: https://ow.ly/ENMz50QEioS